acetylhydrazine has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anh, DT; Dung, DTM; Dung, PTP; Hai, PT; Han, SB; Huy, LD; Jun, HW; Kang, JS; Kwon, JH; Nam, NH; Park, EJ; Tung, TT; Young Ji, A | 1 |
| Anh, DT; Dung, DTM; Han, SB; Kang, JS; Kwon, JH; Na, IH; Nam, NH; Park, EJ; Phan, DTP; Tung, TT | 1 |
| Bhalerao, EB; Bhide, SV; Maru, GB; Sarode, AV | 1 |
3 other study(ies) available for acetylhydrazine and Lung Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents.
Topics: Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Colonic Neoplasms; Fluorouracil; Humans; Hydrazines; Lung Neoplasms; Male; Molecular Docking Simulation; PC-3 Cells; Prostatic Neoplasms; Quinolones; Structure-Activity Relationship | 2022 |
Design, synthesis and evaluation of novel 2-oxoindoline-based acetohydrazides as antitumor agents.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Enzyme Activators; Humans; Hydrazines; Lung Neoplasms; Male; Prostatic Neoplasms | 2022 |
Mutagenicity and carcinogenicity of mono- and diacetyl hydrazine.
Topics: Adenocarcinoma, Papillary; Adenoma; Administration, Oral; Animals; Carcinogens; DNA; Female; Hydrazines; Lung Neoplasms; Male; Mice; Microsomes, Liver; Mutagenicity Tests; Mutagens; Salmonella typhimurium; Testis | 1984 |